FIELD: medicine.
SUBSTANCE: method involves determining absolute value of ratio between lymphocyte number and absolute value of monocyte number in peripheral blood at the end of combine radiation therapy. The ratio is divided by 4.05. The result value being greater than 1, no disease relapse occurrence is predicted during the first observation year. The value being less than 1, tumor growth progress is stated and carcinoma relapse is predicted at the first year after treatment.
EFFECT: enhanced accuracy in detecting pathological process progress before observing clinical manifestations.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING RELAPSES OF UTERINE CERVIX CANCER | 2003 |
|
RU2243766C1 |
| METHOD FOR TREATING LOCAL RELAPSES OF UTERINE CERVICAL CANCER | 2003 |
|
RU2240114C1 |
| METHOD FOR TREATMENT OF UTERUS CERVIX CANCER | 2004 |
|
RU2261706C1 |
| METHOD FOR APPLYING PROLONGED PHARMACOTHERAPY | 2003 |
|
RU2271833C2 |
| METHOD OF INTRACAVITARY THERAPY IN TREATMENT OF PATIENTS WITH CANCER METASTASES INTO VAGINA | 2012 |
|
RU2478374C1 |
| METHOD OF TREATING LOCALLY ADVANCED VAGINAL CANCER | 2012 |
|
RU2493846C1 |
| METHOD OF TREATMENT OF SUPERFICIAL CANCER OF BLADDER | 2007 |
|
RU2350338C2 |
| METHOD OF TREATING TONGUE CANCER | 2012 |
|
RU2488412C1 |
| METHOD FOR TREATING CHRONIC TONSILLITIS | 2003 |
|
RU2235568C1 |
| METHOD FOR TREATING ENDOMETRITIS AFTER APPLYING INTRAUTERINE CONTRACEPTION MEANS | 1998 |
|
RU2160136C2 |
